Oridonin loaded solid lipid nanoparticles enhanced antitumor activity in MCF-7 cells

Journal of Nanomaterials

Volumn 2014, Issue , 2014, Pages

  Wang, Lu ^a   Wang, Shengpeng ^a   Chen, Ruie ^a   Wang, Yanping ^b   Li, Hui ^b   Wang, Yitao ^a   Chen, Meiwan ^a  

^a China jack1987168 163com   (Macao)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL DEATH; HYDROPHOBICITY; NANOPARTICLES;

ANTI-TUMOR ACTIVITIES; CHINESE HERBAL MEDICINES; FLOW-CYTOMETRIC ANALYSIS; HEPATOCELLULAR CARCINOMA; HIGH PRESSURE HOMOGENIZATION; NARROW SIZE DISTRIBUTIONS; SOLID LIPID NANOPARTICLE (SLN); SOLID LIPID NANOPARTICLES;

DRUG PRODUCTS;

EID: 84899533716     PISSN: 16874110     EISSN: 16874129     Source Type: Journal    
DOI: 10.1155/2014/903646     Document Type: Article

References (18)

1. + Treg differentiation, modulates Th1/Th2 balance and induces HO-1 in rat splenic lymphocytes. Inflammation Research 2008 57 4 163 170 2-s2.0-42649101299 10.1007/s00011-007-7193-0
2. Xu Y., Xue Y., Wang Y., Feng D., Lin S., Xu L., Multiple-modulation effects of oridonin on the production of proinflammatory cytokines and neurotrophic factors in LPS-activated microglia. International Immunopharmacology 2009 9 3 360 365 2-s2.0-60349114707 10.1016/j.intimp.2009.01. 002
3. Zhou L., Sun L., Wu H., Oridonin ameliorates lupus-like symptoms of Mrl mice by inhibition of B-cell activating factor (Baff). European Journal of Pharmacology 2013 715 1-3 230 237 10.1016/j.ejphar.2013.05.016
4. Li X.-T., Lin C., Li P.-Y., Characteristics of the cytostatic effects of oridonin in vitro. Zhongguo Yao Li Xue Bao 1986 7 4 361 363 2-s2.0-0022589379 (Pubitemid 16092293)
5. Wang H., Ye Y., Chu J.-H., Zhu G.-Y., Li Y.-W., Fong D. W. F., Yu Z.-L., Oridonin induces G2/M cell cycle arrest and apoptosis through MAPK and p53 signaling pathways in HepG2 cells. Oncology Reports 2010 24 3 647 651 2-s2.0-77956301155 10.3892/or-00000903
6. Guo Y., Shan Q., Gong Y., Oridonin in combination with lmatinib exerts synergetic anti-leukemia effect in Ph+ acute lymphoblastic leukemia cells in vitro by inhibiting activation of Lyn/Mtor signaling pathway. Cancer Biology & Therapy 2012 13 13 1244 1254 10.4161/cbt.21460
7. Wang S., Zhong Z., Wan J., Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells. The American Journal of Chinese Medicine 2013 41 1 177 196 10.1142/S0192415X13500134
8. Liu J. J., Wu X. Y., Lul H. L., Anti-proliferation effect of oridonin on Hl-60 cells and its mechanism. Chinese Medical Sciences Journal 2004 19 2 134 137
9. Hsieh T.-C., Wijeratne E. K., Liang J.-Y., Gunatilaka A. L., Wu J. M., Differential control of growth, cell cycle progression, and expression of NF- B in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the Chinese herb Rabdosia rubescens. Biochemical and Biophysical Research Communications 2005 337 1 224 231 2-s2.0-25844511169 10.1016/j.bbrc.2005.09.040 (Pubitemid 41393783)
10. Hu H.-Z., Yang Y.-B., Xu X.-D., Shen H.-W., Shu Y.-M., Ren Z., Li X.-M., Shen H.-M., Zeng H.-T., Oridonin induces apoptosis via PI3K/Akt pathway in cervical carcinoma Hela cell line. Acta Pharmacologica Sinica 2007 28 11 1819 1826 2-s2.0-35648937054 10.1111/j.1745-7254.2007.00667.x (Pubitemid 350029332)
11. Kang N., Zhang J.-H., Qiu F., Tashiro S.-I., Onodera S., Ikejima T., Inhibition of EGFR signaling augments oridonin-induced apoptosis in human laryngeal cancer cells via enhancing oxidative stress coincident with activation of both the intrinsic and extrinsic apoptotic pathways. Cancer Letters 2010 294 2 147 158 2-s2.0-77953359873 10.1016/j.canlet.2010.01.032
12. Meade-Tollin L. C., Wijeratne E. M. K., Cooper D., Guild M., Jon E., Fritz A., Zhou G.-X., Whitesell L., Liang J.-Y., Gunatilaka A. A. L., Ponicidin and oridonin are responsible for the antiangiogenic activity of Rabdosia rubescens, a constituent of the herbal supplement PC SPES. Journal of Natural Products 2004 67 1 2 4 2-s2.0-9144228626 10.1021/np0304114 (Pubitemid 38141300)
13. Huang J., Wu L., Tashiro S.-I., Onodera S., Ikejima T., Reactive oxygen species mediate oridonin-induced HepG2 apoptosis through p53, MAPK, and mitochondrial signaling pathways. Journal of Pharmacological Sciences 2008 107 4 370 379 2-s2.0-50149087699 10.1254/jphs.08044FP
14. Zhang Y., Wu Y., Wu D., Tashiro S.-I., Onodera S., Ikejima T., NF- b facilitates oridonin-induced apoptosis and autophagy in HT1080 cells through a p53-mediated pathway. Archives of Biochemistry and Biophysics 2009 489 1-2 25 33 2-s2.0-69849112209 10.1016/j.abb.2009.07.017
15. Falamarzian A., Lavasanifar A., Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(e{open}-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B. Colloids and Surfaces B: Biointerfaces 2010 81 1 313 320 2-s2.0-77956010490 10.1016/j.colsurfb.2010.07. 025
16. Gokce E. H., Korkmaz E., Dellera E., Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. International Journal of Nanomedicine 2012 7 1841 1850
17. Wang S., Chen T., Chen R., Hu Y., Chen M., Wang Y., Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies. International Journal of Pharmaceutics 2012 430 1-2 238 246 2-s2.0-84859389555 10.1016/j.ijpharm.2012.03.027
18. Ray R. S., Rana B., Swami B., Venu V., Chatterjee M., Vanadium mediated apoptosis and cell cycle arrest in MCF7 cell line. Chemico-Biological Interactions 2006 163 3 239 247 2-s2.0-33750017625 10.1016/j.cbi.2006.08.006 (Pubitemid 44572229)